EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Purinergic signaling modulates CD4+ T cells with cytotoxic potential during Trypanosoma cruzi infection

Gastón Bergero, Yanina L Mazzocco, Sebastian Del Rosso, Ruining Liu, Zoé M Cejas Gallardo, Simon C Robson, Martin Rottenberg, Maria P Aoki

Journal of Clinical Investigation · 2025

DOI: 10.1172/jci186785 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Gastón Bergero und 7 weiteren Autor:innen. Beteiligte Einrichtung: Universidad Nacional de Córdoba, Facultad de Ciencias Químicas, Departamento de Bioquímica Clínica, Córdoba, Argentina. Hauptthemen laut MEDLINE: Trypanosoma cruzi, CD4-Positive T-Lymphocytes, Signal Transduction, Chagas Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases of the National Institutes of Health, The Swedish Foundation of International Cooperation in Research and Higher Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trypanosoma cruziCD4-Positive T-LymphocytesSignal TransductionChagas DiseaseT-Lymphocytes, CytotoxicHumans5'-NucleotidaseHypoxia-Inducible Factor 1, alpha SubunitApyraseAnimalsFemaleAdenosineAdenosine TriphosphateMaleGPI-Linked ProteinsAntigens, CDMice

Stichwörter der Autor:innen

HypoxiaImmunologyInfectious diseaseInflammationParasitologyT cells

Substanzen

5'-NucleotidaseHypoxia-Inducible Factor 1, alpha SubunitApyraseNT5E protein, humanHIF1A protein, humanAdenosineAdenosine TriphosphateENTPD1 protein, humanGPI-Linked ProteinsAntigens, CD

Autor:innen und Institutionen

  • Universidad Nacional de Córdoba, Facultad de Ciencias Químicas, Departamento de Bioquímica Clínica, Córdoba, Argentina.
  • Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Centro de Investigación en Bioquímica Clínica e Inmunología (CIBICI), Córdoba, Argentina.
  • Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet. Stockholm, Sweden.
  • Center for Inflammation Research, Department of Anesthesia, Critical Care & Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases of the National Institutes of Health
  • The Swedish Foundation of International Cooperation in Research and Higher Education
  • Secretaría de Ciencia y Tecnología, Universidad Nacional de Córdoba
  • Agencia Nacional de Promoción Científica y Tecnológica (ANPCyT) Fondo para la Investigación Científica y Tecnológica

Zitieren

APA

Bergero, G., Mazzocco, Y. L., Del Rosso, S., Liu, R., Cejas Gallardo, Z. M., Robson, S. C., Rottenberg, M., & Aoki, M. P. (2025). Purinergic signaling modulates CD4+ T cells with cytotoxic potential during Trypanosoma cruzi infection. Journal of Clinical Investigation. https://doi.org/10.1172/jci186785

Vancouver

Bergero G, Mazzocco YL, Del Rosso S, Liu R, Cejas Gallardo ZM, Robson SC, et al. Purinergic signaling modulates CD4+ T cells with cytotoxic potential during Trypanosoma cruzi infection. Journal of Clinical Investigation. 2025. doi:10.1172/jci186785

BibTeX
@article{Bergero2025,
  author = {Bergero, Gastón and Mazzocco, Yanina L and Del Rosso, Sebastian and Liu, Ruining and Cejas Gallardo, Zoé M and Robson, Simon C and Rottenberg, Martin and Aoki, Maria P},
  title = {Purinergic signaling modulates CD4+ T cells with cytotoxic potential during Trypanosoma cruzi infection},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci186785}
}
Kostenlos starten →